Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Cancers|July 2, 2021
Blockage of Cholinergic Signaling via Muscarinic Acetylcholine Receptor 3 Inhibits Tumor Growth in Human Colorectal AdenocarcinomaNina A Hering, Verena Liu, Rayoung Kim, et al.International Journal of Colorectal Disease|June 18, 2021
Risk factors for upper and lower type prolonged postoperative ileus following surgery for Crohn's diseaseIoannis Pozios, Hendrik Seeliger, Johannes C Lauscher, et al.Radiation and Environmental Biophysics|January 27, 2022
Thymidine phosphorylase induction by ionizing radiation antagonizes 5-fluorouracil resistance in human ductal pancreatic adenocarcinomaLucas D Lee, Ioannis Pozios, Verena Liu, et al.American Journal of Surgery|April 13, 2010
Risk factors for surgical complications in distal pancreatectomyHendrik Seeliger, Simone Christians, Martin K Angele, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
Blockage of 2-deoxy-D-ribose-induced angiogenesis with rapamycin counteracts a thymidine phosphorylase-based escape mechanism available for colon cancer under 5-fluorouracil therapyHendrik Seeliger, Markus Guba, Gudrun E Koehl, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Rapamycin-induced endothelial cell death and tumor vessel thrombosis potentiate cytotoxic therapy against pancreatic cancerChristiane J Bruns, Gudrun E Koehl, Markus Guba, et al.World Journal of Surgical Oncology|August 20, 2020
Accuracy of various criteria for lymph node staging in ductal adenocarcinoma of the pancreatic head by computed tomography and magnetic resonance imagingFlorian N Loch, Patrick Asbach, Matthias Haas, et al.Molecular Cancer Research : MCR|February 12, 2009
EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinomaHendrik Seeliger, Peter Camaj, Ivan Ischenko, et al.Blood|January 27, 2005
Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGFMarkus Guba, Maksim Yezhelyev, Martin E Eichhorn, et al.Cancers|July 27, 2022
Frequency of Positive Familial Criteria in Patients with Adenocarcinoma of the Esophageal-Gastric Junction and Stomach: First Prospective Data in a Caucasian CohortJan Schölzchen, Christoph Treese, Peter Thuss-Patience, et al.Pageof 5